BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37314251)

  • 1. Whole exome sequencing identifies MAP3K1, MSH2, and MLH1 as potential cancer-predisposing genes in familial early-onset colorectal cancer.
    Fatemi N; Tu SJ; Chung CC; Moghadam PK; Mojarad EN; Sadeghi A; Totonchi M; Aghdaei HA; Chang JG
    Kaohsiung J Med Sci; 2023 Sep; 39(9):896-903. PubMed ID: 37314251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
    Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
    World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
    Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
    Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of mutations in genes associated with familial colorectal cancer syndrome (MLH1, MSH2, PMS2, MSH6, and APC): A not so common hereditary cancer syndrome in Indian population.
    Bhai P; Kulshrestha S; Puri RD; Bijarnia Mahay S; Saxena R; Verma IC
    Indian J Gastroenterol; 2020 Dec; 39(6):599-607. PubMed ID: 33191490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.
    Jiang TJ; Wang F; Wang YN; Hu JJ; Ding PR; Lin JZ; Pan ZZ; Chen G; Shao JY; Xu RH; Zhao Q; Wang F
    Cancer Commun (Lond); 2020 Nov; 40(11):620-632. PubMed ID: 32914570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel candidates in early-onset familial colorectal cancer.
    Jansen AML; Ghosh P; Dakal TC; Slavin TP; Boland CR; Goel A
    Fam Cancer; 2020 Jan; 19(1):1-10. PubMed ID: 31555933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
    Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
    [No Abstract]   [Full Text] [Related]  

  • 12. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next generation sequencing screening of Lynch syndrome in Tunisian population.
    Ben Sghaier R; Jansen AML; Bdioui A; Van Wezel T; Ksiaa M; Elgolli L; Ben Fatma L; Ben Ahmed S; Azzouz MM; Hellara O; Elghali A; Darbel F; Skandrani K; Mokkni M; Gdissa A; Ltaief R; Saad A; Hmila F; Gribaa M; Morreau H
    Fam Cancer; 2019 Jul; 18(3):343-348. PubMed ID: 31114938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing in 51 early onset non-familial CRC cases.
    Thutkawkorapin J; Lindblom A; Tham E
    Mol Genet Genomic Med; 2019 May; 7(5):e605. PubMed ID: 30809968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
    Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
    Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients.
    Petersen SM; Dandanell M; Rasmussen LJ; Gerdes AM; Krogh LN; Bernstein I; Okkels H; Wikman F; Nielsen FC; Hansen TV
    BMC Med Genet; 2013 Oct; 14():103. PubMed ID: 24090359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of known and novel familial cancer genes in Swedish colorectal cancer families.
    Helgadottir HT; Thutkawkorapin J; Rohlin A; Nordling M; Lagerstedt-Robinson K; Lindblom A
    Int J Cancer; 2021 Aug; 149(3):627-634. PubMed ID: 33729574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer.
    Toma C; Díaz-Gay M; Franch-Expósito S; Arnau-Collell C; Overs B; Muñoz J; Bonjoch L; Soares de Lima Y; Ocaña T; Cuatrecasas M; Castells A; Bujanda L; Balaguer F; Cubiella J; Caldés T; Fullerton JM; Castellví-Bel S
    Int J Cancer; 2020 Mar; 146(6):1568-1577. PubMed ID: 31525256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.